CSPC Pharmaceutical Group (STU:CVG) Market Cap: €10,218 Mil (As of Jul. 05, 2026)


STU:CVG CSPC Pharmaceutical Group Ltd STU:CVG
51 GF Score
Price €0.88
GF Value €0.72
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is CSPC Pharmaceutical Group Market Cap?

CSPC Pharmaceutical Group STU:CVG +4.54% 51 Market Cap is €10,218 Mil as of Jul. 05, 2026. GuruFocus rates STU:CVG with a GF Score™ of 51/100 and a GF Value™ of €0.72 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 1,022 Drug Manufacturers companies, CSPC Pharmaceutical Group ranks better than 95.21% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CSPC Pharmaceutical Group's share price for the quarter that ended in Dec. 2025 was €0.9098. CSPC Pharmaceutical Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 11,405 Mil. Therefore, CSPC Pharmaceutical Group's market cap for the quarter that ended in Dec. 2025 was €10,377 Mil.

CSPC Pharmaceutical Group's quarterly market cap increased from Jun. 2025 (€9,270 Mil) to Sep. 2025 (€11,413 Mil) but then declined from Sep. 2025 (€11,413 Mil) to Dec. 2025 (€10,377 Mil).

CSPC Pharmaceutical Group's annual market cap declined from Dec. 2023 (€9,761 Mil) to Dec. 2024 (€6,616 Mil) but then increased from Dec. 2024 (€6,616 Mil) to Dec. 2025 (€10,377 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CSPC Pharmaceutical Group's Enterprise Value for Today is €9,325 Mil.


CSPC Pharmaceutical Group  (STU:CVG) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


CSPC Pharmaceutical Group Market Cap Related Terms


CSPC Pharmaceutical Group Market Cap Historical Data

* Premium members only.

The historical data trend for CSPC Pharmaceutical Group's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group Market Cap Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,993.98 11,577.61 9,761.11 6,616.25 10,376.68

CSPC Pharmaceutical Group Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,578.40 9,269.74 11,413.31 10,376.68 11,382.64

STU:CVG vs LLY, JNJ, ABBV: Market Cap Comparison

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Market Cap distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Market Cap falls into.


STU:CVG
51GF Score
CSPC Pharmaceutical Group Ltd STU:CVG
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSPC Pharmaceutical Group Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

CSPC Pharmaceutical Group's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=€0.9098*11405.452
=€10,377

CSPC Pharmaceutical Group's Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=€0.9098*11405.452
=€10,377

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €10,218 Mil mean?
CSPC Pharmaceutical Group (STU:CVG) has a Market Cap of €10,218 Mil as of Jul. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CSPC Pharmaceutical Group and its competitors. According to the industry distribution chart, CSPC Pharmaceutical Group ranks #49 out of 1022 companies in the Drug Manufacturers industry, placing it in the top 4.8%.
Is CSPC Pharmaceutical Group's Market Cap too high?
CSPC Pharmaceutical Group's current Market Cap is €10,218 Mil. Based on the distribution chart, CSPC Pharmaceutical Group ranks #49 out of 1022 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, CSPC Pharmaceutical Group has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Market Cap compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, CSPC Pharmaceutical Group ranks #49 out of 1022 companies for Market Cap. This places CSPC Pharmaceutical Group in the top 5% of its industry — outperforming the majority of peers. The industry median Market Cap is 221.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 221.60, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CSPC Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Market Cap is 221.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CSPC Pharmaceutical Group's current Market Cap is €10,218 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group (STU:CVG) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.72, compared to a current price of €0.88 — trading 21.5% above its estimated fair value. The current Market Cap is €10,218 Mil. CSPC Pharmaceutical Group's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For CSPC Pharmaceutical Group (STU:CVG), the current Market Cap is €10,218 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSPC Pharmaceutical Group (STU:CVG) Overvalued in 2026?

Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued. The current stock price of €0.88 is trading 21.5% above its estimated GF Value™ of €0.72. GuruFocus considers CSPC Pharmaceutical Group to be Modestly Overvalued.

Key valuation signals for STU:CVG:

  • Market Cap: €10,218 Mil
  • GF Value™: €0.72 vs. price of €0.88 (21.5% above fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the STU:CVG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CSPC Pharmaceutical Group Business Description

Address No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
51GF Score

Get the complete analysis for STU:CVG

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.88
Price
€0.72
GF Value